The "FMHR" traders reveal their final trades, including Alibaba, Cisco and more.
The "FMHR" panel discuss Warren Buffett, Dow Chemical and their preferred stock agreement.
The "FMHR" panel discuss how hedge funds are under pressure, passive vs. active investing and which method is best.
The FMHR traders take their positions on four stocks making news today, including Tiffany, Signet Jewelers and more.
The "FMHR" traders discuss today's 'Call of the Day' which is Netflix.
CNBC's Meg Tirrell reports the latest on the drug price debate, Teva on a generic EpiPen and the FDA. David Maris, Wells Fargo analyst, and the "FMHR" traders weigh in.
The "FMHR" panel and David Maris, specialty pharmaceutical analyst at Wells Fargo Securities, discuss the latest on the EpiPen pricing outrage.
The "Fast Money" traders give you 5 trades in retail heading into back to school season.
The "Fast Money" traders share their final trades of the day.
Joe Dennison, Zevenbergen Capital Investments Associate Portfolio Manager, discusses the SolarCity bond offering to Elon Musk and his cousins the Rive brothers. The "Fast Money" traders weigh in.
Former Apple CEO John Sculley discusses what he sees as the innovation and growth prospects for the tech giant.
Former Apple CEO John Sculley discusses Steve Jobs' legacy at Apple and Tim Cook's five-year anniversary as CEO.
CNBC's Dominic Chu reports on the record amounts of cash being hoarded by some of America's biggest companies. The "Fast Money" traders weigh in.
The "Fast Money" traders discuss the plunge in the GDX gold miners ETF with gold hitting a one-month low ahead of Fed Chair Janet Yellen's remarks at Jackson Hole.
Umer Raffat, Evercore ISI Senior Analyst, discusses how Mylan's stock price may be affected long-term by the EpiPen pricing saga.
The "Fast Money" traders discuss the effect of Mylan's EpiPen pricing controversy on the biotech sector.
The "Halftime Report" experts debate whether or not to buy Tiffany and Signet going into earnings
The "FMHR" traders reveal their final trades, including Lending Club and Amgen.
Jon Najarian tracks big options moves in Chico's.
Piper Jaffray upgrades energy to overweight. The "FMHR" panel discuss this as their call of the day.